Wednesday, April 11, 2018

RubrYc Therapeutics Spins Out Of HealthTell, Gets $10M

San Ramon-basd RubrYC Therapeutics, which says it is focused on using chemical libraries from HealthTell, Inc. to improve drug discovery throughput, has raised $10M in a Series A funding. The funding was led by Third Point Ventures, and also included Paladin Capital Group and Vital Venture Capital. RubrYc's CEO is Dr. Isaac Bright. The company said the funding completes its spin-off from HealthTell. More information »